BRAVE Act of 2025
Summary
The BRAVE Act of 2025 is an early-stage authorization bill expanding VA mental health services with zero new funding. It has no direct revenue impact on private hospital operators HCA and UHS. Both stocks have declined sharply over the past 30 days driven by broader healthcare sector headwinds, not this procedural legislation.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.BRAVE Act appropriates $0 — no new money for VA mental health programs
- 2.No revenue catalyst for HCA or UHS — private hospitals not impacted by this authorization-only bill
- 3.Both HCA (-9.72%) and UHS (-5.94%) declines over 30 days are sector-wide, not legislative-driven
Market Implications
No market implications for HCA or UHS from the BRAVE Act. Both stocks are trading lower due to broader healthcare sector trends (inflation, labor costs, utilization normalization), not legislative catalysts. HCA at $427.24 has lost nearly 10% in 30 days, approaching its 52-week low of $330. UHS at $168.34 is down ~6% over the same period. The absence of any direct revenue or regulatory connection between this VA authorization bill and private hospital operations means investors should ignore this legislation for HCA and UHS positioning.
Full Analysis
The BRAVE Act of 2025 (HR6024) was introduced on November 12, 2025 by Rep. Jason Crow (D-CO) and referred to the Veterans' Affairs and Armed Services committees. The bill authorizes expanded VA mental health workforce waivers, Vet Center infrastructure improvements, and extends the Staff Sergeant Parker Gordon Fox Suicide Prevention Grant Program through fiscal year 2026. However, the bill explicitly appropriates zero new funding—all programs are authorized subject to future appropriations bills. The bill remains in early legislative stages, referred to subcommittee on December 3, 2025, with an identical companion bill (S609) also pending in the Senate.
The money trail stops at authorization: the BRAVE Act is a policy bill that sets program parameters without allocating a single dollar. Actual funding would require a separate VA appropriations bill, which has not been introduced. For private sector companies like HCA Healthcare (HCA) and Universal Health Services (UHS), there is no revenue mechanism—VA care is delivered through VA facilities and directly contracted community providers, not general private hospital admissions under this bill.
Structural winners and losers: There are no identifiable winners or losers in the private hospital sector from this bill. The primary beneficiaries would be VA employees and VA-contracted community providers, but no publicly traded companies are named in the bill text. The legislation focuses on VA licensure waivers for mental health counselors, Vet Center outreach assessments, and studies—none of which generate revenue for HCA or UHS. The bill does not expand VA purchasing of private sector care.
Real market data shows HCA at $427.24 on April 30, 2026, down 9.72% over 30 days from approximately $473, and down 1.21% over 7 days. UHS at $168.34 is down 5.94% over 30 days and 3.45% over 7 days. These declines align with broader healthcare sector pressure—not this procedural bill. HCA's 52-week range of $330-$556.52 and UHS's $152.33-$246.33 indicate stocks trading near the lower half of their ranges amid sector-wide weakness.
Timeline: As of April 30, 2026, the bill has been in subcommittee for nearly five months with no further action. With zero funding and bipartisan but low-profile sponsorship (8 cosponsors, none from leadership), passage probability is low in the current session. Even if enacted, the bill would not affect private hospital company financials.
Intelligence Surface
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
No confirming evidence found yet from contracts, insider trades, or congressional activity
What the bill does
Authorization bill with zero appropriated funds for VA mental health services; no direct revenue catalyst for private hospital operators
Who must act
HCA Healthcare (publicly traded for-profit hospital chain)
What happens
No change in reimbursement rates, patient volumes, or regulatory requirements for HCA's hospitals
Stock impact
HCA derives ~100% of revenue from inpatient and outpatient care; the bill does not expand private hospital eligibility for VA contracts or alter Medicare/Medicaid payments. Recent 30-day decline of -9.72% is driven by broader sector trends, not this legislation
What the bill does
Authorization bill with zero appropriated funds for VA mental health services; no direct revenue catalyst for private behavioral health operators
Who must act
Universal Health Services (publicly traded behavioral and acute care hospital chain)
What happens
No change in reimbursement rates, patient volumes, or regulatory requirements for UHS's behavioral health facilities
Stock impact
UHS operates ~335 behavioral health facilities and ~26 acute care hospitals; the bill does not expand private provider participation in VA programs. Recent 30-day decline of -5.94% is driven by broader sector trends, not this legislation
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
SPREZZATURA MANAGEMENT CONSULTING, LLC: $23.2M Department of Veterans Affairs Contract
Physician and Patient Safety Act
Nurse Staffing Standards for Hospital Patient Safety and Quality Care Act of 2025
Veterans’ Assuring Critical Care Expansions to Support Servicemembers (ACCESS) Act of 2025
CAPEX & D SQUARE, A JOINT VENTURE LLC: $23.2M Department of Veterans Affairs Contract
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Debt Collection Practices (Regulation F); Deceptive and Unfair Collection of Medical Debt".
To amend title XVIII of the Social Security Act to prevent hospitals or skilled nursing facilities that are owned by certain firms from participating in the Medicare program.
CHOICE for Veterans Act of 2025
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security
President Trump issued a proclamation exempting certain chemical manufacturing facilities from compliance with the EPA's HON Rule for two years, citing unavailability of required technology and national security concerns. The exemption delays emissions-control deadlines and maintains pre-HON Rule standards for listed stationary sources, invoking authority under Clean Air Act section 112(i)(4).
Advancing Regenerative Agriculture and Strengthening American Farm Resilience
This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →